- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01214070
Functional Vision in TBI
June 14, 2017 updated by: VA Office of Research and Development
Functional Vision Consequences of Rehabilitation for TBI Vision Loss
The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI.
Study Overview
Status
Terminated
Conditions
Detailed Description
Traumatic brain injury (TBI) can cause vision loss because of diffuse or focal neuronal injury.
Vision can be compromised because of local injury to one or both optic nerves, diffuse brain injury, and/or limitation in eye movements because of dysfunction of cranial nerves.
These typical injuries may compromise any of the neural pathways that subserve afferent or efferent visual function.
Self-reports of vision loss include diplopia, visual field loss, light sensitivity, reading problems and contrast sensitivity (color and luminance) loss.
This project will pursue the following aims: 1) Identify the relationship between functional vision loss in everyday vision tasks (reading, visual search, way finding) and the characteristics of potential visual impairment (visual acuity, contrast sensitivity, visual fields, stereoacuity, eye movement disorders) associated with TBI; and 2) Determine the ability of the vision rehabilitation interventions (both monotherapy and combination therapy) to improve functional vision outcome measures that reflect everyday visual tasks.
The vision rehabilitation interventions incorporated into this study will be Vision Restoration Therapy, NVT Eye Scanning Therapy, and standard Eccentric Viewing Training.
These therapies are rehabilitative interventions prescribed for Veterans in Polytrauma Rehabilitation Centers, Blind Rehabilitation Centers, and advocated for VA Medical Center TBI clinics.
Study Type
Interventional
Enrollment (Anticipated)
110
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304-1290
- VA Palo Alto Health Care System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 77 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- TBI (any form)
- Hemianopic Visual Field Loss
- Stable fixation
- 1.0 logMAR or better Reading Acuity
- 20 words per minute or better reading rate
Exclusion Criteria:
- Visual Neglect
- medical conditions that prevent sitting for 30 minutes or following instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Arm 1
Group 1 - Combination Treatment
|
Therapy that enhances the neuronal plasticity of the visual system
Therapy that trains eye and head scanning into the blind hemianoptic visual field
|
Active Comparator: Arm 2
Group 2 - Combination Treatment
|
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
|
Active Comparator: Arm 3
Group 3 - Combination Treatment
|
Therapy that enhances the neuronal plasticity of the visual system
Therapy that trains eye and head scanning into the blind hemianoptic visual field
|
Active Comparator: Arm 4
Group 4 - Combination Treatment
|
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
|
Active Comparator: Arm 5
Group 5 - Monotherapy Treatment
|
Therapy that enhances the neuronal plasticity of the visual system
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
|
Active Comparator: Arm 6
Group 6 - Monotherapy Treatment
|
Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
|
Active Comparator: Arm 7
Group 7 - Monotherapy Treatment
|
Therapy that trains eye and head scanning into the blind hemianoptic visual field
Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Dynamic Visual Field
Time Frame: Baseline
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Dynamic Visual Field
Time Frame: After First Therapy / Before Second Therapy (Average time is 4.5 months)
|
After First Therapy / Before Second Therapy (Average time is 4.5 months)
|
Dynamic Visual Field
Time Frame: After Second Therapy (Average Time is 9 months)
|
After Second Therapy (Average Time is 9 months)
|
Reading Rate and Accuracy
Time Frame: Baseline
|
Baseline
|
Reading Rate
Time Frame: After First Therapy / Before Second Therapy (average time is 4.5 months)
|
After First Therapy / Before Second Therapy (average time is 4.5 months)
|
Reading Rate and Accuracy
Time Frame: After Second Therapy (average time is 9 months)
|
After Second Therapy (average time is 9 months)
|
Visual Search Accuracy and Timing
Time Frame: Baseline
|
Baseline
|
Visual Search Accuracy and Timing
Time Frame: After First Therapy / Before Second Therapy (average time is 4.5 months)
|
After First Therapy / Before Second Therapy (average time is 4.5 months)
|
Visual Search Accuracy and Timing
Time Frame: After Second Therapy (average time is 9 months)
|
After Second Therapy (average time is 9 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ron Schuchard, PhD, VA Palo Alto Health Care System
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2012
Primary Completion (Actual)
November 21, 2013
Study Completion (Actual)
November 21, 2013
Study Registration Dates
First Submitted
September 14, 2010
First Submitted That Met QC Criteria
September 30, 2010
First Posted (Estimate)
October 4, 2010
Study Record Updates
Last Update Posted (Actual)
June 16, 2017
Last Update Submitted That Met QC Criteria
June 14, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C6687-R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injuries
-
Eunice Kennedy Shriver National Institute of Child...CompletedTraumatic Brain Injuries
-
Technical University of MunichFederal Ministry of Defence (Germany); Bundesministerium der VerteidigungRecruitingTraumatic Brain InjuriesFrance, Germany
-
University of Colorado, DenverBinghamton University; Brooke Army Medical CenterRecruitingBrain ConcussionUnited States
-
University of Alabama at BirminghamCompletedTraumatic Brain InjuriesUnited States
-
More FoundationElMindA Ltd; Riddell, LLC; Mimic SystemsUnknownAthletic Injuries | Concussion, BrainUnited States
-
La Trobe UniversityRecruitingAnterior Cruciate Ligament Injuries | Concussion, Brain | Musculoskeletal InjuryAustralia
-
Bayside HealthVictorian Trauma FoundationCompletedTraumatic Brain Injury | Multiple Trauma | Spinal InjuriesAustralia
-
Mosaic Life CareMissouri Western State UniversityTerminatedBrain Injuries | Brain Concussion | Athletic Injuries | Diffuse Axonal Injury | Injury, Brain, TraumaticUnited States
-
Association de Recherche Bibliographique pour les...University of Cambridge; Centre Hospitalier Princesse Grace; Institut National...CompletedBrain Injuries | Sport Injury | Concussion, BrainMonaco
-
Henry M. Jackson Foundation for the Advancement...U.S. Army Medical Research and Development CommandCompletedTraumatic Brain Injury | Brain ConcussionAfghanistan
Clinical Trials on Vision Restoration Therapy
-
Emory UniversityCompletedNon-Arteritic Anterior Ischemic Optic NeuropathyUnited States
-
Beth Israel Deaconess Medical CenterCompletedScotoma | Hemianopia | Quadrantanopia | Visual Field Loss
-
University of MagdeburgCompletedBrain Injuries, Traumatic | HemianopiaGermany
-
University of California, BerkeleyNational Eye Institute (NEI)Completed
-
Pennsylvania College of OptometryNational Eye Institute (NEI)CompletedConvergence InsufficiencyUnited States
-
Shahid Beheshti University of Medical SciencesUnknownStrabismusIran, Islamic Republic of
-
Universitat Politècnica de CatalunyaRecruitingVision Disorders | Binocular Vision Disorder | Eye; Movement Disorder (Binocular) | Vision TherapySpain
-
Retina Implant AGCompletedRetinitis PigmentosaGermany
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)Terminated